HUMANE CD30 LIGAND ANTIGEN BINDENDE PROTEINE

Patent europeic · EP2841456 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2841456
Numer da la dumonda
EP13720714
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
25-04-2013
Publitgà
04-03-2015
Concedì
13-06-2018
La protecziun finescha il pli tard
24-04-2033
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
C07K 16/28 (2006.01)
Prioritad
US 201261639637 P 27.04.2012
Dumonda PCT
PCT/US2013/038135 25.04.2013
Publicaziun PCT
WO2013/163377 31.10.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  3. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  4. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  5. 12-09-2018

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 12.09.2018

  6. 13-06-2018

    Concedì

    Published in Swissreg on 13.06.2018

Partidas

Possessur

Novo Nordisk A/S

Novo Allé, 2880 Bagsværd, DK

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

ANDERSEN, Mette, Dahl

2880 Bagsværd, DK

DANTZLER, Jeff

Seattle, WA 98133, US

ARMITAGE, Richard, J.

Bainbridge Island, WA 98110, US

CLARK, Rutilio

Bainbridge Island, WA 98110, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.